BRTX
BioRestorative Therapies Inc

3,822
Mkt Cap
$6.05M
Volume
4.85M
52W High
$2.10
52W Low
$0.19
PE Ratio
-0.19
BRTX Fundamentals
Price
$0.2799
Prev Close
$0.2562
Open
$0.2615
50D MA
$0.6464
Beta
1.35
Avg. Volume
17.7M
EPS (Annual)
-$1.16
P/B
1.02
Rev/Employee
$36,454.54
$0.3838
Loading...
Loading...
News
all
press releases
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
More News
News Placeholder
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of -17.02% and -72.90%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 2.6% - Should You Sell?
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 2.6% - What's Next...
MarketBeat·17d ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9% - Here's Why
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9% - What's Next...
MarketBeat·1mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.6% - Here's Why
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 2.6% - Time to Sell...
MarketBeat·2mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 1.8% - Should You Sell?
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.8% - Here's What Happened...
MarketBeat·3mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.7% - Time to Sell?
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 2.7% - Here's Why...
MarketBeat·3mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Up 6.4% - What's Next?
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 6.4% - Here's What Happened...
MarketBeat·4mo ago
News Placeholder
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of 0.00% and -97.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Earnings Outlook For BioRestorative Therapies
read more...
Benzinga·4mo ago
<
1
2
...
>

Latest BRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.